Blood thinner after spinal surgery for cancer that spread to spine
Treatments studied
Part of Bones, joints & muscles, Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether a daily blood thinner pill (apixaban) for 30 days after spine surgery can safely prevent blood clots in people with cancer that spread to the spine. It is for patients who are going home or to a rehab facility, not hospice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You had spine surgery for cancer that spread to the spine at a participating UPMC hospital
- You plan to go home or to a rehab facility after the hospital, not hospice
- You can take pills by mouth and have a telephone for follow-up calls
- You are not already on a blood thinner for another reason (like a prior clot or heart condition)
- You have not had major bleeding problems in the past 6 months and your blood counts and kidney/liver tests are within the study's limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
This trial tests different ways to take the blood thinner apixaban to prevent blood clots in people with cancer who are starting or switching their cancer treatment. It aims to find the best dose for safety and effectiveness.
This trial tests if apixaban, a blood thinner pill, can prevent dangerous blood clots in people with advanced lung cancer who are receiving outpatient chemotherapy or other systemic treatments. It aims to reduce the risk of venous thromboembolism (blood clots in veins) during cancer therapy.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.